Skip to main content
GIVLAARI 189 mg/mL injection, solution by Alnylam Pharmaceuticals, Inc.
GIVLAARI, 189 mg/mL, injection, solution Drug class: Aminolevulinate Synthase 1-directed RNA Interaction; Small Interfering RNA. Available on prescription only. Listed by Alnylam Pharmaceuticals, Inc..
Prescription only

GIVLAARI

givosiran sodium

Listed by Alnylam Pharmaceuticals, Inc.

Strength
189 mg/mL
Form
Injection, Solution
Route
Subcutaneous
Class
Aminolevulinate Synthase 1-directed RNA Inter…

What it contains

  • Givosiran Sodium 189 mg/mL

FDA record

Dosage form Injection, Solution
Route Subcutaneous
Drug class Aminolevulinate Synthase 1-directed RNA Interaction; Small Interfering RNA
Approval route NDA — original brand approval
NDC code 71336-1001
FDA application NDA212194
RxNorm concept 2265716
Package sizes listed 1
Marketed since December 2019

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.